“The pharmaceutical sector in Switzerland is a major industry, accounting for approximately 7% of GDP, and 35% of manufacturing.” The Swiss pharma business is the largest pharma bu...
Environmental, social, and governance (ESG) funds are becoming increasingly popular worldwide. Institutional investors and shareholders are increasingly looking for impact investme...
“Environmental, social and governance (ESG) strategy is quickly moving from a ‘good’ to a ‘must-have’ strategy for pre-IPO companies preparing to enter the market.” In recent years...